pharmatechoutlook
MAY 20245TECH OUTLOOKC O NT E NT SCXO INSIGHTSCXO INSIGHTSNavigating Through Drug Discovery and DevelopmentExploring the Dynamic Frontiers in Drug DiscoveryStefano Biondi,Head of Pre-Clinical,Recordati S.p.A.Scott Daniels,SVP Drug Metabolism & Pharmacokinetics, andAndrew Brown,Director of Drug Discovery Portfolio Marketing,Inotiv1618Microbiological Considerations for Achieving Drug Manufacturing ExcellenceGeneric Drug Products Development ­ Challenges and OverviewJessica Wilson Rayse,Assoc Director of Product Management, Accugenix,Charles River LaboratoriesSuci Ameliya Reza Zairizal,Associate Manager,Novugen2224Early Phase Biologics Characterization; a Key Factor for Risks Mitigation in Biologics Product DevelopmentsRafael Sande,Head Operations Characterization,Large Molecule / ATMP Services,Solvias AG26Launching and Promoting Drugs in the Fields of Cardiology, Pulmonology, and OTCHrvoje Tomic,Group Product Manager Croatia & Slovenia,Servier20PG 28TOP 10 TECH OUTLOOKDRUG DISCOVERY AND DEVELOPMENTSOLUTIONS PROVIDERS - 2024
< Page 4 | Page 6 >